Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia.
about
Conditioning regimens for hematopoietic cell transplantation: one size does not fit allEfficiency of high-dose cytarabine added to CY/TBI in cord blood transplantation for myeloid malignancy.G-CSF priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasm.Relapse after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes: Analysis of Late Relapse Using Comparative Karyotype and Chromosome Genome Array TestingConditioning regimens in acute myeloid leukemia.Hematopoietic Cell Transplantation for Older Patients with MDS.Reduced-intensity conditioned allogeneic SCT in adults with AML.Acute myeloid leukemia: 2016 Update on risk-stratification and management.Conditioning regimens for allogeneic hematopoietic stem cell transplants in acute myeloid leukemia.Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndrome: Experience of the Argentinean Group of Bone Marrow Transplantation (GATMO).The gp130 Cytokine Interleukin-11 Regulates Engraftment of Vav1-/- Hematopoietic Stem and Progenitor Cells in Lethally Irradiated Recipients.Pharmacokinetics and Pharmacodynamics of Treosulfan in Patients With Thalassemia Major Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.
P2860
Q33917170-41BFF2E1-940E-409A-8F4A-E63475962273Q35859239-7B5AC1AF-CBA1-466F-B11E-A199BC326AF9Q36478979-E6E27EB8-1F47-4EF3-B501-38E97CCB1052Q36635154-ADE69CDD-8758-4EB4-9FAB-B7670411A080Q38229633-081A5084-73D5-4EF3-9F20-F6E98066F27EQ38252578-48BA442E-380E-473A-A19E-54C23236E4E1Q38366632-BFAA7A07-EFC3-4E0E-86B3-5457CB57E719Q38897289-F31A9AB0-46BF-4A96-BE7E-28CA64B6D534Q39306717-907CA4D5-6D43-4407-9C2A-6ADD24A43042Q40280061-56708B29-5C36-4B07-8496-93029867C581Q40766061-9147C339-1321-4F56-8E3A-4A41D908C5F1Q47319422-C3BE1FB5-5822-4401-BA2E-220417679060Q48106141-673AB83F-3F82-4B05-B603-7C3F3435BFFBQ48596388-F579E772-EA9E-4C7D-9B83-DB1BCF13C539
P2860
Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treosulfan, fludarabine, and 2 ...... me and acute myeloid leukemia.
@en
Treosulfan, fludarabine, and 2 ...... me and acute myeloid leukemia.
@nl
type
label
Treosulfan, fludarabine, and 2 ...... me and acute myeloid leukemia.
@en
Treosulfan, fludarabine, and 2 ...... me and acute myeloid leukemia.
@nl
prefLabel
Treosulfan, fludarabine, and 2 ...... me and acute myeloid leukemia.
@en
Treosulfan, fludarabine, and 2 ...... me and acute myeloid leukemia.
@nl
P2093
P2860
P50
P1476
Treosulfan, fludarabine, and 2 ...... me and acute myeloid leukemia.
@en
P2093
Aravind Ramakrishnan
Bart Scott
Boglarka Gyurkocza
Brent Wood
Colleen Delaney
Elihu H Estey
Eneida R Nemecek
Filippo Milano
Joachim Baumgart
John M Pagel
P2860
P304
P356
10.1016/J.BBMT.2014.01.009
P577
2014-01-16T00:00:00Z